Renalytix Share Discussion Threads

[1jat] 17/6/2024 11:48

The coverage determination enables Medicaid to pay for tests.

FDA approval, inclusion in treatment guidelines and now billable under Medicaid, the test and analysis is fully endorsed.

However not many clinicians have used the test yet……the credibility and expectation of use should drive take up.

US Clinicians are averse to taking on legal risk - and so will follow the guidelines.
The company probably needs to find an ambulance chasing lawyer to prosecute some cases where the test should have been used but was not.

[bertiebingo] 16/6/2024 16:59

Why is last weeks news so important?

[collywobbler] 16/6/2024 15:33

If you think you’re too late here try verici dx. Poised for greatness in a similar sector

[bri15] 14/6/2024 14:22

Ivan there still plenty of gains to be had here.

[ivan danko] 14/6/2024 13:55

Im too late to get in now..damn..

[bri15] 14/6/2024 13:46

US 20% up,that's just the start.

[bri15] 14/6/2024 13:44

F..k aye it is 😀

[ivan danko] 14/6/2024 13:17

Is this a promising company..i mean 14mil kits to US at 950 dollars...

[bri15] 14/6/2024 13:05

I be glued to Nasdaq on open,it's got to start high,and then keep rising, they will know the importance of today's RNS, unlike UK fools

[bri15] 14/6/2024 13:03

Yank market will rocket this.

[bri15] 14/6/2024 11:55

This will be in the 20's by cop.

[bri15] 14/6/2024 11:54

It's about to fly!

[1jat] 14/6/2024 09:43

Now get some sales…..game on

[bri15] 14/6/2024 09:28

So glad I topped up this morning,this is going to fly later when yanks wake up.

[mr roper] 29/5/2024 14:32

CFO going..3 years too late. On its way to the bin now

[tradertrev] 20/5/2024 10:40

Is that toast I can smell?

[bertiebingo] 18/5/2024 15:06

Tragic results, back to a gross profit loss with revenues down qoq.

[faz] 14/5/2024 16:17

Mills sold 2.5m shares for £500k, When they were £11 a share that was worth £27m. Nice going. Remind me to listen to Chris Mills next time he spouts on about investments.

[pre] 14/5/2024 12:25

rns out - Harwood capital reduced their holding here, down from 10.78% now holding 8.68%

[iceagefarmer] 01/5/2024 15:32

rumour of takeover.. ig stopped taking bets

[1jat] 11/4/2024 16:30

The company has not given any thoughts on margins, but I would compare it with Pharma where product cost is typically 20% and sales/general costs another 30% for an established product….
There would be costs anyway in operating the test, so the incremental costs of outsourcing might push the lab cost up by a further 10-20%….should still be profitable…but it does allow scalability which is key to RENX being able to penetrate the addressable market.

[f56] 09/4/2024 19:24

OK.I hear what you are saying. How do you think that would translate into profit for RENX if they have to follow that kind of model?

[1jat] 09/4/2024 16:26

F56 - how relevant is the invitae case to RENX?
I expect RENX has the IP/technology and will licence testing to labs….they certainly dont have the infrastructure to set up labs, lab cost will take a chunk of the $950 tariff for the test.

[f56] 08/4/2024 18:27

Invitae, the testing company, have just gone bankrupt in the US. They managed a significant turnover before running out of cash.